Showing results (491-500 of 501) with videos related to
Sort By:
Pageof 51
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|December 20, 2021
Humoral Responses After SARS-CoV-2 mRNA Vaccination and Breakthrough Infection in Cancer PatientsSaranya Chumsri, Pooja P Advani, Tanmayi S Pai, et al.Journal of Gastrointestinal Oncology|December 3, 2013
Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutionsAaron T Wild, Susan M Hiniker, Daniel T Chang, et al.Biomedicines|August 26, 2023
Survival Outcomes in T3 Laryngeal Cancers: Primary Total Laryngectomy vs. Concurrent Chemoradiation or Radiation Therapy-A Meta-AnalysisKarthik Nagaraja Rao, Prathamesh S Pai, Prajwal Dange, et al.Oncotarget|February 18, 2020
Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancerVanita Noronha, Vijay Maruti Patil, Amit Joshi, et al.Annals of Surgery|June 11, 2020
Outcomes of Elective Major Cancer Surgery During COVID 19 at Tata Memorial Centre: Implications for Cancer Care PolicyShailesh V Shrikhande, Prathmesh S Pai, Manish S Bhandare, et al.Cancer|December 25, 2014
Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinomaJoseph M Herman, Daniel T Chang, Karyn A Goodman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2017
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority TrialVanita Noronha, Amit Joshi, Vijay Maruti Patil, et al.Brain : a Journal of Neurology|July 25, 2020
Early-infantile onset epilepsy and developmental delay caused by bi-allelic GAD1 variantsCaroline Neuray, Reza Maroofian, Marcello Scala, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2023
Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based ChemoradiationVijay Maruti Patil, Vanita Noronha, Nandini Menon, et al.Cancer|June 1, 2019
A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancerVijay Maruti Patil, Vanita Noronha, Amit Joshi, et al.Pageof 51